Medicus Pharma (NASDAQ:MDCX) announced on Monday that it has submitted an optimized Phase 2 clinical study protocol to the US ...
The path forward is clear: Accounting functions must become AI-ready, moving beyond incremental automation to a future state ...
China’s ambitious plans to build a space-based solar power station are drawing renewed attention ...